KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Invested Capital (2017 - 2026)

Guardant Health's Invested Capital history spans 9 years, with the latest figure at -$99.3 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 28.89% to -$99.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$99.3 million, a 28.89% increase, with the full-year FY2025 number at -$99.3 million, up 28.89% from a year prior.
  • Invested Capital hit -$99.3 million in Q4 2025 for Guardant Health, up from -$354.5 million in the prior quarter.
  • Over the last five years, Invested Capital for GH hit a ceiling of $847.0 million in Q1 2021 and a floor of -$354.5 million in Q3 2025.
  • Historically, Invested Capital has averaged $178.0 million across 5 years, with a median of $113.5 million in 2023.
  • Biggest five-year swings in Invested Capital: soared 253.27% in 2024 and later crashed 18838.31% in 2025.
  • Tracing GH's Invested Capital over 5 years: stood at $645.0 million in 2021, then plummeted by 90.67% to $60.2 million in 2022, then soared by 163.68% to $158.7 million in 2023, then crashed by 188.0% to -$139.6 million in 2024, then rose by 28.89% to -$99.3 million in 2025.
  • Business Quant data shows Invested Capital for GH at -$99.3 million in Q4 2025, -$354.5 million in Q3 2025, and -$305.5 million in Q2 2025.